AtriCure (NASDAQ:ATRC) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 1000 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $153.600 million which beat the analyst consensus estimate of $151.842 million by 1.16 percent. This is a 12.83 percent increase over sales of $136.139 million the same period last year.